Sara Cazzaniga
Clinical R&D Manager Italfarmaco S.p.A., LinkedIn
"We have found that the team at Trials24 has a solid understanding of the recruitment issues relating to clinical trials in rare disease and are enjoyable and professional to work with. They efficiently set up the complete process of patient community involvement including the clinical trial website, and everything was specific and tailored to our needs. We were very impressed with the number of interested and eligible patients going up exponentially within short time...”
Dr. med. Peter Uebel
Specialist in Internal Medicine, Haus der Gesundheit Ludwigshafen, LinkedIn
“In a recent study, Trials 24 greatly supported recruiting potential study participants. Thanks to good pre-selection, we recruited some patients for the study. We were very grateful for this support. We have been established as a study center in internal and gastroenterological studies for more than 20 years. During this time, we have often used supporting campaigns in patient acquisition. Often with little success or a lack of pre-selection, which previously represented an ineffective additional burden.“
Dr. med. René Goedkoop
Acting Chief Medical Officer, Medigene AG, LinkedIn
"We embraced Admedicum’s services, in collaboration with Trials24, only by the time that we became aware that the inclusion of patients with certain hematologic malignancies in an ongoing phase I study of a PRAME-specific TCR-T was not as expected due to the very restrictive nature of the eligibility criteria. The team’s experience and creativity towards a fruitful approach to our reality of clinical study conduct within Germany..."
"We have found that the team at Trials24 has a solid understanding of the recruitment issues relating to clinical trials in rare disease and are enjoyable and professional to work with. They efficiently set up the complete process of patient community involvement including the clinical trial website, and everything was specific and tailored to our needs. We were very impressed with the number of interested and eligible patients going up exponentially within short time..."
Sara Cazzaniga
Clinical R&D Manager Italfarmaco S.p.A., LinkedIn
"In a recent study, Trials 24 greatly supported recruiting potential study participants. Thanks to good pre-selection, we recruited some patients for the study. We were very grateful for this support. We have been established as a study center in internal and gastroenterological studies for more than 20 years. During this time, we have often used supporting campaigns in patient acquisition. Often with little success or a lack of pre-selections, which previously represented an ineffective additional burden."
Dr. med. Peter Uebel
Specialist in Internal Medicine, Haus der Gesundheit Ludwigshafen, LinkedIn
"We embraced Admedicum’s services, in collaboration with Trials24, only by the time that we became aware that the inclusion of patients with certain hematologic malignancies in an ongoing phase I study of a PRAME-specific TCR-T was not as expected due to the very restrictive nature of the eligibility criteria. The team’s experience and creativity towards a fruitful approach to our reality of clinical study conduct within Germany..."
Dr. med. René Goedkoop
Acting Chief Medical Officer, Medigene AG, LinkedIn
Trials24 GmbH
Trials24 accelerates patient recruitment to support biopharmaceutical companies and CROs complete their clinical trials on time, bringing innovative drugs to patients faster.
© Copyright | Trials24 GmbH
